we performed the co-expression analysis and confirmed that CAPG2 positively correlates with the expressions of well-defined glioma stem cell marker genes, including Sox2, CD44, MYC and CCND1 (Figure 11A). The gene discussed is CD44; the disease is central nervous system cancer.